RSS

Nemaura Pharma

Results of recent clinical trials carried out on type 1 diabetics by Nemaura Pharma using its Memspatch insulin micro-needle device (IMD) reportedly show promising results for patients with a phobia of needles and injections. more

23 May 2017 14:00 Devices